1. Peters, G.J., Van Dijk, J., Nadal, J.C., Van Groeningen, C.J., Lankelma, J. and Pinedo, H.M. (1987) Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo
1, 113–118.
2. Harris, B.E., Song, R. and Diasio, R.B. (1990) Relationship between Dihydropyrimidine Dehydrogenase Activity and Plasma 5-Fluorouracil Levels with Evidence for Circadian Variation of Enzyme Activity and Plasma Drug Levels in Cancer Patients Receiving 5-Fluorouracil by Protracted Continuous Infusion. Cancer Res. 50, 197–201.
3. Van Kuilenburg, A.B.R, Van Lenthe, H., and Van Gennip, A.H. (1996) Identification and Tissue-Specific Expression of a NADH-Dependent Activity of Dihydropyrimidine Dehydrogenase in Man. Anticancer Res. 16, 389–394.
4. Peters, G.J., Lankelma, J., Kok, R.M., Noordhuis, P., Van Groeningen, C.J., Van der Wilt, C.L., Meyer, S. and Pinedo, H.M. (1993) Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. Cancer Chemother. Pharmacol. 31, 269–276.
5. Harris, B.E., Song, R., He, Y.-J., Soong, S.-J. and Diasio, R.B. (1988) Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Biochem. Pharmacol. 37, 4759–4762.